-
Margarita Calonge
Ocular Surface Group, IOBA-Universidad de Valladolid, Valladolid, Spain
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain
-
Alberto López-Miguel
Ocular Surface Group, IOBA-Universidad de Valladolid, Valladolid, Spain
VISIÓN I+D, SL, Valladolid, Spain
-
Marisa Tesón
Ocular Surface Group, IOBA-Universidad de Valladolid, Valladolid, Spain
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain
-
Vicente Martin-Montanez
Ocular Surface Group, IOBA-Universidad de Valladolid, Valladolid, Spain
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain
-
Amalia Enriquez-De-Salamanca
Ocular Surface Group, IOBA-Universidad de Valladolid, Valladolid, Spain
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain
-
Michael E Stern
Biological Sciences, Allergan Inc, Irvine, CA
-
Maria-Jesus J. Gonzalez
Ocular Surface Group, IOBA-Universidad de Valladolid, Valladolid, Spain
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain